The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, has licensed PSMA-1007 from ABX-...
Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer.
Oncuria is the first-of-its-kind multiplex urine test for the...
